What predicts the change from episodic to chronic migraine?

Current Opinion in Neurology

Volumn 22, Issue 3, 2009, Pages 269-276

  Bigal, Marcelo E ^a,b,d   Lipton, Richard B ^b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Montefiore Headache Center   (United States)

^d Global Director for Scientific Affairs at Neuroscience   (United States)

Author keywords

Chronic migraine; Risk factors; Transformed migraine

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; OPIATE DERIVATIVE; TRIPTAN DERIVATIVE;

ALLODYNIA; BEHAVIOR THERAPY; BODY MASS; BODY WEIGHT; CLUSTER HEADACHE; COMORBIDITY; DISEASE COURSE; DOSE RESPONSE; HUMAN; MIGRAINE; OBESITY; PAIN; PATIENT CARE; PATIENT MONITORING; PROPHYLAXIS; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SNORING; TRANSFORMED MIGRAINE; TREATMENT PLANNING;

ANALGESICS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DISEASE PROGRESSION; HUMANS; MENTAL DISORDERS; MIGRAINE DISORDERS; OBESITY; PAIN; RISK FACTORS; SLEEP APNEA SYNDROMES; STRESS, PSYCHOLOGICAL;

EID: 67049108840     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32832b2387     Document Type: Review

References (46)

1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006; 5:148-157.
2. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47:871-875.
3. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27:102-106.
4. Bigal ME, Upton RB. Clinical course in migraine: conceptualizing migraine transformation. Neurology 2008; 71:848-855. This study conceptualizes migraine transformation in three possibilities: clinical transformation (development of chronic migraine); functional progression (development of cutaneous allodynia); and anatomical progression (deep brain lesions).
5. Scher Al, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998; 38:497-506.
6. Bigal ME, Rapoport AM, Lipton RB, et al. Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 2003; 43:336-342.
7. Scher Al, Stewart WF, Ricci J A, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106:81-89.
8. Bigal ME, Lipton RB. The prognosis of migraine. Curr Opin Neurol 2008; 21:301-308.
9. Ulrich V, Gervil M, Fenger K, et al. The prevalence and characteristics of migraine in twins from the general population. Headache 1999; 39:173-180.
10. Rueda-Sanchez M, Diaz-Martinez LA. Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cepha-lalgia 2008; 28:216-225. A study reporting family aggregation of chronic migraine.
11. Castillo J, Munoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-196.
12. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62:788-790.
13. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001; 41:629-637.
14. Goadsby PJ. Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006; 2:401.
15. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43:179-190.
16. Paemeleire K, Evers S, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008; 12:122-127. The above article reports that daily triptan use for cluster headache was associated with chronic migraine in individuals with migraine but not in cluster individuals without migraine.
17. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001; 41:303-309.
18. Williams L, O'Connell K, Tubridy N. Headaches in a rheumatology clinic: when one pain leads to another. Eur J Neurol 2008; 15:274-277.
19. Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004; 62:1540-1544.
20. Zwart JA, Dyb G, Hagen K, et al. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003; 61:160-164.
21. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48:1157-1168.
22. Dodick DW. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache. Headache 2002; 42:547-554.
23. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007; 47:355-363.
24. Schonewille WJ. Chronic daily headaches caused by too much caffeine. Ned Tijdschr Geneeskd 2002; 146:1861-1863.
25. Shapiro RE. Caffeine and headaches. Curr Pain Headache Rep 2008; 12:311-315. The above article reviews the topic of caffeine inducing chronic daily headaches.
26. Scher Al, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004; 63:2022-2027.
27. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327:1109-1114.
28. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006; 66:545-550.
29. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006; 67:252-257.
30. Bigal ME, Tsang A, Loder E, et al. Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007; 167:1964-1970.
31. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 2007; 68:1851-1861. The above article discusses putative mechanisms of the migraine obesity relationship.
32. Bigal ME, Lipton RB. Putative mechanisms of the relationship between obesity and migraine progression. Curr Pain Headache Rep 2008; 12:207-212.
33. Jennum P, Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992; 1:240-244.
34. Scher Al, Lipton RB, Stewart WF. Habitual snoring as a risk factor for chronic daily headache. Neurology 2003; 60:1366-1368.
35. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004; 55:27-36.
36. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55:19-26.
37. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23:23-32.
38. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47:614-624.
39. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol 2008; 63:148-158. A study suggesting that allodynia is more prevalent in chronic than episodic migraine.
40. Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008; 70:1525-1533.
41. Breslau N, Andreski P. Migraine, personality, and psychiatric comorbidity. Headache 1995; 35:382-386.
42. Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003; 10:147-152.
43. Karakurum B, Soylu O, Karatas M, et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci 2004; 114:1391-1399.
44. Scher Al, Stewart WF, Buse D, et al. Major life changes before and after the onset of chronic daily headache: a population-based study. Cephalalgia 2008; 28:868-876. The above article showed that stressful life events increased the risk of chronic migraine.
45. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression (or for chronic daily headaches): clinical lessons. Headache 2006; 46 (Suppl 3): S144-S146.
46. Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache 2008; 48:7-15.